Verona Pharma is developing novel treatments to enhance the lives of those affected by chronic lung conditions.

Patients
Understanding the impact of chronic respiratory conditions on patients’ daily lives is vital to improving care.
To learn more about Verona Pharma, please get in touch.
Effective October 7th, 2025, Verona Pharma Plc and it subsidiaries1 are subsidiaries of Merck & Co., Inc. (Rahway, New Jersey USA)
1 Subsidiaries include Verona Pharma, Inc. (US) and Verona Pharma Ireland Limited (Ireland).
For product-related questions, please contact us at
1-888-672-0371
Monday – Friday 8:30 AM – 5:00 PM ET
To report suspected adverse reactions, contact Verona Pharma, Inc, at
1-888-672-0371
Monday – Friday 8:30 AM – 5:00 PM ET